Showing results (251-260 of 352) with videos related to

Sort By:
Pageof 36
The Journal of Pathology|November 20, 2014
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerizationMin Li, Silvia Armelloni, Cristina Zennaro, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2015
A Podocyte-Based Automated Screening Assay Identifies Protective Small MoleculesHa Won Lee, Samia Q Khan, Mohd Hafeez Faridi, et al.
Developmental Cell|June 21, 2017
Apoptosis and Compensatory Proliferation Signaling Are Coupled by CrkI-Containing MicrovesiclesKajal H Gupta, Josef W Goldufsky, Stephen J Wood, et al.
Plos One|September 30, 2010
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular diseasePaola Krall, Cesar P Canales, Pamela Kairath, et al.
American Journal of Physiology. Renal Physiology|January 15, 2015
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosisNamiko Kobayashi, Toshiharu Ueno, Kumi Ohashi, et al.
Scientific Reports|April 30, 2021
Application of regularized regression to identify novel predictors of mortality in a cohort of hemodialysis patientsStanislas Werfel, Georg Lorenz, Bernhard Haller, et al.
Kidney International|August 3, 2020
Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndromeXiaochen Liu, Gloria Michelle Ducasa, Shamroop Kumar Mallela, et al.
American Journal of Human Genetics|March 1, 2011
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathyNadine Norton, Duanxiang Li, Mark J Rieder, et al.
Journal of the American Heart Association|February 25, 2020
Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery DiseaseAnurag Mehta, Shivang R Desai, Yi-An Ko, et al.
Pageof 36